Saturday November 21 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
  • A-Z


          

Malvern’s chemical imaging system helps solve a major challenge in paediatric drug development

5 November 2009: Malvern, UK: Researchers at the Institute of Pharmaceutics and Biopharmaceutics at the University of Düsseldorf in Germany have taken delivery of a Near Infrared Chemical Imaging (NIR-CI) system from Malvern Instruments (Malvern, UK). Able to deliver rapid, robust and flexible spatial and chemical information, the Sapphire system was selected for its wide sampling dynamic range and depth of field. The ideal solution for analyzing curved tablets, whole granules and pellets, and anything in between, the new instrument is set to transform many of the Institute’s ground-breaking projects in novel solid drug dosage forms. The system is already being used by Prof. Dr. J. Breitkreutz and his research team for testing oral drug-loaded films, also called wafers, in a project designed to tackle the difficulties of administering drugs to young children.

Prof. Dr. Jörg Breitkreutz said; “Paediatric drug delivery is a major challenge. There is currently a lack of suitable and safe solid drug formulations for children and new EU legislation will enforce paediatric clinical trials and drug development. Current advances in this area include interesting new drug delivery concepts such as multiparticulate dosage forms, minitablets, fast-dissolving formulations, small-sized oral films and wafers designed to stick to the roof of the patient’s mouth. However, novel dosage forms often need special methods to assess their properties for both development and quality control as standard testing procedures are not available in the pharmacopoeias. This increases the need for flexible analytical methodology and instrumentation. Malvern’s near infrared chemical imaging system accommodates the sample variability encompassed by modern pharmaceutical development and was therefore our ideal solution for visualization of drug distribution within the dosage forms.”

On 29th May 2009 the European Journal of Pharmaceutics and Biopharmaceutics published a paper authored by Verena Garsuch and Jörg Breitkreutz. Entitled; ‘Novel analytical methods for the characterization of oral wafers’, the paper describes a study that aims to compensate for the lack of adequate methods for the characterization of the novel wafers by applying advanced analytical techniques1. The Malvern chemical imaging system plays a critical role within the morphological investigation as it can depict visually unrecognized differences in the distribution of the active pharmaceutical ingredient within wafers. Further information regarding the application of NIR-CI in pharmaceutical development can be found at: http://www.malvern.com/NIRCI

1 V. Garsuch, J. Breitkreutz, “Novel analytical methods for the characterization of oral wafers”
Eur. J. Pharm. Biopharm. 73:195-201 (2009)

Malvern, Malvern Instruments and SyNIRgi are registered trademarks of Malvern Instruments Ltd

High resolution image attached or available from Trish Appleton,
Kapler Communications trish@kapleronline.com  Ref: MAL/JOB/1857

CAPTION: NIR chemical image of caffeine-loaded oral film. Red pixels indicate high concentrations of caffeine in the matrix of excipients and isolated red dots advancing crystallization of caffeine.



About Malvern Instruments
Malvern Instruments provides a range of complementary materials characterization tools that deliver inter-related measurements reflecting the complexities of particulates and disperse systems, nanomaterials and macromolecules. Analytical instruments from Malvern are used in the characterization of a wide variety of materials, from industrial bulk powders to nanomaterials and delicate macromolecules. A broad portfolio of innovative technologies is combined with intelligent, user-friendly software. These systems deliver industrially relevant data enabling our customers to make the connection between micro (such as particle size) and macro (bulk) material properties (rheology) and chemical composition (chemical imaging).

Particle size, particle shape, zeta potential, molecular weight, chemical composition and rheological properties measurements are now joined by advanced chromatography solutions (GPC/SEC), extending Malvern’s technologies for protein molecular weight, size and aggregation measurements, and synthetic polymer molecular weight and distribution. The company’s laboratory, at-line, on-line and in-line solutions are proven in sectors as diverse as cement production and pharmaceutical drug discovery.

Headquartered in Malvern, UK, Malvern Instruments has subsidiary organizations in all major European markets, North America, China, Korea and Japan, a joint venture in India, a global distributor network and applications laboratories around the world. www.malvern.com 

For press information, please contact:
Trish Appleton, Kapler Communications
Knowledge Centre, Wyboston Lakes, Great North Road,
Wyboston, Bedfordshire, MK44 3BY, UK
Tel: +44 (0)1480 479280; Fax: +44 (0)1480 470343 trish@kapleronline.com

USA contact:
Marisa Fraser, Malvern Instruments Inc.
117 Flanders Road, Westborough, MA 01581-1042 USA
Tel: +1 508 768 6400 Fax: +1 508 768 6403 marisa.fraser@malvern.com

Please send sales enquiries to:
Alison Vines, Malvern Instruments Ltd
Enigma Business Park, Grovewood Road, Malvern, Worcestershire WR14 1XZ UK
Tel: +44 (0) 1684 892456; Fax: +44 (0) 1684 892789 salesinfo@malvern.com
 


 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright © 1997-2009 - BioPortfolio Limited.